Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)

Summary

The intervention proposed is a new organization of care, based on the EXPRIM (EXtrem PRematurity Innovative Management) protocol, involving early, standardized, and multidisciplinary management of women hospitalized for a risk of extremely preterm birth and their children. It will take place in each perinatal network for all pregnant women hospitalized between 22 and 26 weeks with a risk of preterm delivery.

Setting up the protocol requires taking into account the parents' time and timing issues, and its potential for change, to plan the implementation of the protocol, especially the degree of emergency of the situation and the probability of imminent delivery.

The follow-up collected for this study will take place:

* At D4 post-delivery: A questionnaire about the parents' experience of the information delivered and the decisions made will be given to and collected from the parents
* At Day 28, post-delivery: A questionnaire about the parents' experience of care for their child will be given to and collected from the mother and the co-parent.
* At the child's discharge from the hospital, or if he or she dies in the hospital:

* Collection of clinical data (principal endpoint) from data in the medical file.
* Data to measure practices and adherence to the intervention will be collected
* When the child reaches the corrected age of 2 years:

* a short questionnaire will be completed by the physician caring for the child at the corrected age of 2 years. The data collected will concern motor and sensory development, in particular, cerebral palsy, blindness, and deafness..
* Information about the child's development will also be collected with a questionnaire including a standardized assessment scale, he PARCA-R questionnaire (Parent Report of Children's Abilities-Revides), which the parents will complete.

Conditions

• Newborn
• Extreme Prematurity
• Pretrm Infants

Interventions

OTHER

Premex Protocol

This protocol presupposes stages during which staff are informed and trained. It is based on the following principles: * Administration of corticosteroid therapy to all eligible women, independent of the decision about active or palliative care * A prognostic evaluation in a non-emergency meeting of the obstetricians and neonatologists/pediatricians involved, no longer based only on gestational age, and enabling the team to provide consistent, consensual, and individualized information to parents; * A joint decision about the obstetric and neonatal (active or palliative) care to be proposed to parents at the end of this evaluation; * An interview with parents, also on non-emergency basis, to give them information about the child's prognosis and the management proposed, to answer their questions, and to obtain their opinion; * Management at birth consistent with that decided in consultation with the parents.

Sponsors & Collaborators

• URC-CIC Paris Descartes Necker Cochin

  collaborator OTHER

• Assistance Publique - Hôpitaux de Paris

  lead OTHER

Principal Investigators

• Pierre-Henri JARREAU, MD, PhD · Assistance Publique - Hôpitaux de Paris

• Pierre-Yves ANCEL, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SEQUENTIAL

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-06-01

Primary Completion

2026-08-31

Completion

2026-12-31

Countries

• France

Study Locations